Gene · 8764
Papers3,537
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 3,537
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Characterization and Prognosis of Biological Microenvironment in Lung Adenocarcinoma through a Disulfidptosis-Related lncRNAs Signature. | Genet Res (Camb) | 2023 | 37575978 | PubTator, text mining | PubMed |
| Comparison of antiviral responses in two bat species reveals conserved and divergent innate immune pathways. | iScience | 2023 | 37575178 | PubTator, text mining | PubMed |
| Integrative multi-omics analyses unravel the immunological implication and prognostic significance of CXCL12 in breast cancer. | Front Immunol | 2023 | 37564657 | PubTator, text mining | PubMed |
| Lysine N-methyltransferase SETD7 promotes bladder cancer progression and immune escape via STAT3/PD-L1 cascade. | Int J Biol Sci | 2023 | 37564199 | PubTator, text mining | PubMed |
| Novel insights into the pathogenesis of follicular lymphoma by molecular profiling of localized and systemic disease forms. | Leukemia | 2023 | 37563306 | PubTator, text mining | PubMed |
| The clinical and molecular taxonomy of t(14;18)-negative follicular lymphomas. | Blood Adv | 2023 | 37561599 | PubTator, text mining | PubMed |
| Herpesvirus entry mediator as a potential biomarker in breast cancer compared with conventional cytotoxic T‑lymphocyte‑associated antigen 4. | Biomed Rep | 2023 | 37560313 | PubTator, text mining | PubMed |
| Prognostic and immune infiltrative biomarkers of CENPO in pan-cancer and its relationship with lung adenocarcinoma cell proliferation and metastasis. | BMC Cancer | 2023 | 37558987 | PubTator, text mining | PubMed |
Emerging entities: high-grade/large B-cell lymphoma with 11q aberration, large B-cell lymphoma with IRF4 rearrangement, and new molecular subgroups in large B-cell lymphomas. A report of the 2022 EA4HP/SH lymphoma workshop. | Virchows Arch | 2023 | 37555980 | PubTator, text mining | PubMed |
| Identification of hepatocellular carcinoma-related subtypes and development of a prognostic model: a study based on ferritinophagy-related genes. | Discov Oncol | 2023 | 37555866 | PubTator, text mining | PubMed |
| LIGHT (TNFSF14) promotes the differentiation of human bone marrow-derived mesenchymal stem cells into functional hepatocyte-like cells. | PLoS One | 2023 | 37552689 | PubTator, text mining | PubMed |
| Immune gene signatures as prognostic criteria for cancer patients. | Ther Adv Med Oncol | 2023 | 37547445 | PubTator, text mining | PubMed |
| Identification and validation of a genetic risk signature associated with prognosis in clear-cell renal cell carcinoma patients. | Medicine (Baltimore) | 2023 | 37543772 | PubTator, text mining | PubMed |
| A novel metabolic subtype with S100A7 high expression represents poor prognosis and immuno-suppressive tumor microenvironment in bladder cancer. | BMC Cancer | 2023 | 37543645 | PubTator, text mining | PubMed |
| Case report: Clinicopathological and molecular characteristics of pediatric-type follicular lymphoma. | Front Pediatr | 2023 | 37539011 | PubTator, text mining | PubMed |
| Circulating immune cell dynamics as outcome predictors for immunotherapy in non-small cell lung cancer. | J Immunother Cancer | 2023 | 37536935 | PubTator, text mining | PubMed |
| Identification of cuproptosis-related molecular subtypes and a novel predictive model of COVID-19 based on machine learning. | Front Immunol | 2023 | 37533853 | PubTator, text mining | PubMed |
| Disulfidptosis-associated LncRNAs index predicts prognosis and chemotherapy drugs sensitivity in cervical cancer. | Sci Rep | 2023 | 37528124 | PubTator, text mining | PubMed |
| Cuproptosis/ferroptosis-related gene signature is correlated with immune infiltration and predict the prognosis for patients with breast cancer. | Front Pharmacol | 2023 | 37521466 | PubTator, text mining | PubMed |
| Novel mutations in UL24 and gH rescue efficient infection of an HSV vector retargeted to TrkA. | Mol Ther Methods Clin Dev | 2023 | 37519407 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8764/papers?page=23